Fusobacteriota: A Focused Look at an Often-Low Gut Phylum

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

Measures Fusobacteriota levels in your gut or oral microbiome to flag overgrowth linked with colorectal cancer, periodontal disease, and certain inflammatory conditions. Early detection helps prompt medical follow‑up or targeted interventions to reduce those health risks.

Read more →

Understand what your gut health results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

A focused look at an often-low phylum

A fusobacteriota test is a focused gut microbiome analysis that measures the DNA of bacteria in the Fusobacteriota phylum—most notably Fusobacterium—in a stool sample. Modern sequencing (16S rRNA profiling or whole‑genome metagenomics) identifies the types and relative abundance of microbes present, allowing a readout of how much Fusobacteriota shows up compared to the rest of your bacterial community. Because this is a snapshot of a living ecosystem, results reflect current balance rather than a permanent trait, and they can shift with diet, oral health, stress, or recent antibiotics. Method matters: 16S region choice and lab pipelines can influence detection, and very low‑abundance organisms may fall below reporting thresholds.

Why focus on Fusobacteriota? Research has linked elevated Fusobacterium—especially F. nucleatum—to mucosal inflammation, periodontal disease, and enrichment in some colorectal tumors, where it can interact with the immune system and tumor microenvironment (though screening cutoffs in stool are not standardized). In everyday biology, Fusobacteriota can translocate from the mouth to the gut, interact with the intestinal barrier, and participate in signaling that nudges immunity toward or away from inflammation. Understanding its relative level helps contextualize digestive health, oral–gut connections, and colon ecosystem stability.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

What makes this phylum worth a spotlight

In real life, people notice patterns—bloating after a stressful week, looser stools after antibiotics, or flares that track with gum bleeding. A fusobacteriota test helps translate those lived experiences into biology. Higher‑than‑expected Fusobacteriota can point to oral–gut seeding, a stressed gut lining, or a community that favors inflammatory signaling. Lower or undetectable levels generally align with a more fiber‑nourished, diverse microbiome where butyrate‑producing species have the upper hand. Testing can also clarify the impact of recent antibiotics or restrictive diets that thin out microbial diversity, making it easier for opportunists to gain a foothold. It’s especially useful after major routine changes, with persistent GI symptoms, or when oral health concerns and gut issues travel together.

Zooming out, your gut microbiome is a central regulator of whole‑body health—modulating glucose responses, immune tone, and even mood via the gut–brain axis. Tracking Fusobacteriota alongside broader diversity and function helps you see whether your daily inputs (fiber, sleep regularity, workout recovery habits) are steering the ecosystem toward resilience. The goal isn’t to chase a perfect number; it’s to learn your pattern and use that insight to support prevention, earlier evaluation when needed, and steadier long‑term health. Findings are not a diagnosis, but they can be a valuable nudge toward timely clinical conversations—especially for those with ongoing symptoms or relevant family history.

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

Interpreting low, modest, and elevated values

Your report typically shows Fusobacteriota as a percentage of total bacterial DNA, often compared with a reference population. In many healthy adults, Fusobacteriota is low or undetectable; modest detection can be normal, especially with recent oral issues or transient shifts. Balanced microbiomes usually feature greater overall diversity and robust representation of beneficial genera (like Bifidobacterium and butyrate producers such as Faecalibacterium), with Fusobacteriota held to a low relative abundance. Remember that “normal” spans a range—genetics, geography, and diet shape your baseline.

When Fusobacteriota trends higher, it may indicate a community leaning toward inflammation, oral–gut translocation, or reduced competition from protective species. Mechanistically, a lower‑fiber, higher‑refined‑sugar pattern can deprive butyrate producers of fuel, while stress hormones and poor sleep alter gut motility and barrier function—conditions where opportunists may flourish. Elevated results are a signal to contextualize: are there ongoing GI symptoms, recent antibiotics, or gum disease? They suggest a functional pattern worth exploring with your clinician rather than a stand‑alone diagnosis. In pregnancy, invasive infection with Fusobacterium has been linked to adverse outcomes in rare cases, but stool findings alone do not diagnose risk—clinical evaluation guides care.

What the reading can and can't do

Big picture: fusobacteriota test results are most actionable when viewed over time and alongside other markers. Pairing them with fecal calprotectin (inflammation), metabolic labs, or even a colorectal cancer screening plan based on age and risk can sharpen the story. Also note limitations: stool reflects luminal microbes more than those adherent to the mucosa; different sequencing methods have different sensitivity; and a single time point can be skewed by a recent illness or diet swing. Taken together with your history, routines, and goals, the data can help personalize strategies that support digestion, energy, and long‑term gut resilience—without overpromising what microbiome science is still working to nail down.

Frequently Asked Questions

References

  1. Jovel J, Patterson J, Wang W, Hotte N, O'Keefe S, Mitchel T, Perry T, Kao D, Mason AL, Madsen KL, Wong GK (2016). Characterization of the gut microbiome using 16S or shotgun metagenomics. *Frontiers in Microbiology*, *7*, 459. https://doi.org/10.3389/fmicb.2016.00459
  2. Ou S, Wang H, Tao Y, Luo K, Ye J, Ran S, Guan Z, Wang Y, Hu H, Huang R (2022). Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism. *Frontiers in Cellular and Infection Microbiology*, *12*, 1020583. https://doi.org/10.3389/fcimb.2022.1020583
  3. Mann ER, Lam YK, Uhlig HH (2024). Short-chain fatty acids: Linking diet, the microbiome and immunity. *Nature Reviews Immunology*, *24*(8), 577-595. https://doi.org/10.1038/s41577-024-01014-8
  4. Lynch SV, Pedersen O (2016). The human intestinal microbiome in health and disease. *New England Journal of Medicine*, *375*(24), 2369-2379. https://doi.org/10.1056/NEJMra1600266
  5. Allaband C, McDonald D, Vázquez-Baeza Y, Minich JJ, Tripathi A, Brenner DA, Loomba R, Smarr L, Sandborn WJ, Schnabl B, Dorrestein P, Zarrinpar A, Knight R (2019). Microbiome 101: Studying, analyzing, and interpreting gut microbiome data for clinicians. *Clinical Gastroenterology and Hepatology*, *17*(2), 218-230. https://doi.org/10.1016/j.cgh.2018.09.017

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Biological age 32 — a Superpower member portraitA health system built around you — test, understand, optimize150+ biomarkers across 2 blood drawsWhat to expect with Superpower — week 1 to month 3Trusted by 64,000+ customers — member reviewsBetter than the status quo — Superpower vs the old way60% of members found something a doctor missed — member survey
Daniel OSuperpower memberDavid LSuperpower memberRachel DSuperpower memberCamelia VSuperpower member

4.6 · 64,000+ members

Superpower health membership

Find early signs of 1,000+ conditions - then act, retest, and see what changed.

$349

/year*

150+ biomarkers annually across baseline + retest

Personalized plan that turns results into action

Superpower AI and on-demand care team

Results in 10 days or less

At-home or 2,000+ labs nationwide**

Yearly membership$0.96 / dayHSA/FSA eligible

*Pricing may vary for members in New York and New Jersey

**At-home labs for an additional cost

What we test

TestosteroneFree T4Vitamin DApoBHbA1cThyroid (TSH)hs-CRPFerritinCortisolFasting insulin

60%

found something a doctor missed

93%

rated it more useful than their checkup

77%

found something new in their results

Superpower member survey, 90 days post action plan (n=143).

How does the Superpower membership work?

We test 150+ biomarkers annually across two blood draws. Your baseline test paints a comprehensive picture of your health, and your dashboard shows what’s working, what needs attention, and what to do next. Superpower AI and your care team help you take action across lifestyle, supplements, and treatments. Then we retest to track your progress and continue refining your plan.

Can I cancel anytime?

Yes. You can cancel anytime, no fees. Your membership stays active through the end of your paid year.

How often should I test?

Your membership includes two blood tests per year: one to establish your baseline, and one to see whether your plan improved biomarkers that were out of range or not yet optimized. You can add other diagnostics anytime through the app or with help from your care team.

When will I get my results?

Book your draw at any of 2,000+ partner labs or at-home. Results are typically ready in about a week and land in the Superpower app.

What the 100+ panel measures

All 101 markers in your annual baseline draw, organized by system. Nothing here is an upsell.

Heart & Vascular Health

26

  • Apolipoprotein B
  • Atherogenic Coefficient
  • Atherogenic Index of Plasma
  • Castelli Risk Index I
  • Castelli Risk Index II
  • HDL Cholesterol
  • LDL Cholesterol
  • LDL/HDL Ratio
  • Cholesterol, Total
  • Non-HDL Cholesterol
  • Cholesterol/HDL Ratio
  • Carbon Dioxide, Total
  • High-sensitivity CRP
  • hsCRP-to-Albumin Ratio (CAR)
  • GGT-to-HDL Cholesterol Ratio
  • LDL-C to Apolipoprotein B Ratio (LDL-C/ApoB)
  • LDL Cholesterol / Total Cholesterol (Mass Ratio)
  • Monocyte-to-HDL Ratio (MHR)
  • Neutrophil-to-HDL Cholesterol Ratio (NHR)
  • Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB)
  • NON-HDL Total Cholesterol Ratio
  • Triglyceride HDL Molar Ratio
  • Triglycerides
  • Triglyceride-to-Apolipoprotein B Ratio (TG/ApoB)
  • TyG Index
  • Uric Acid

Metabolic Health

4

  • Estim. Avg Glu (eAG)
  • Eag (mmol/l)
  • Glucose
  • Hemoglobin A1c

Energy

1

  • Cortisol

Liver Health

15

  • Albumin/Globulin Ratio
  • Albumin
  • Alkaline Phosphatase (ALP)
  • Alanine Aminotransferase (ALT)
  • Aspartate Aminotransferase (AST)
  • Bilirubin Direct
  • Bilirubin Indirect
  • Bilirubin, Total
  • Bilirubin-to-Albumin Ratio
  • Ferritin
  • Ferritin-to-Albumin Ratio
  • y-Glutamyl Transferase (GGT)
  • Globulin, Total
  • Indirect-to-Direct Bilirubin Ratio
  • Protein, Total

Kidney

11

  • Calcium
  • Chloride
  • Corrected Calcium (Albumin-adjusted)
  • Creatinine
  • Estimated Glomerular Filtration Rate (eGFR)
  • Potassium
  • Sodium
  • BUN/Creatinine Ratio
  • Blood Urea Nitrogen (BUN)
  • Urea-to-Creatinine Ratio
  • Uric Acid-to-HDL Cholesterol Ratio (UHR)

Sex Hormones

7

  • DHEA-Sulfate (DHEA-S)
  • Free Androgen Index
  • Sex Hormone Binding Globulin (SHBG)
  • Free Testosterone
  • Testosterone, Bioavailable
  • Testosterone, Total
  • Testosterone-to-Estradiol Ratio (T/E₂)

Thyroid Health

4

  • Free Thyroxine Index
  • T3 Uptake
  • T4 (thyroxine) Total
  • Thyroid-Stimulating Hormone (TSH)

Nutrients

13

  • Vitamin D
  • Red Cell Dist Width (RDW)
  • Hematocrit
  • Hemoglobin
  • Total Iron Binding Capacity (TIBC)
  • Iron
  • Iron Saturation
  • Mean Cell Hemoglobin (MCH)
  • Mean Corpuscular Hemoglobin Concentration (MCHC)
  • Mean Cell Volume (MCV)
  • Platelet-to-WBC Ratio (PWR)
  • Red Blood Cells
  • RDW MCV Ratio

Immune System

12

  • Basophils
  • Baso (Absolute)
  • Eosinophils
  • Eos (Absolute)
  • Lymphocytes
  • Lymphs (Absolute)
  • Monocytes
  • Monocytes (Absolute)
  • Neutrophils
  • Neutrophils (Absolute)
  • Mean Platelet Volume
  • Platelet Count

Inflammation

8

  • Lymphocyte-to-Monocyte Ratio (LMR)
  • Monocyte-to-Lymphocyte Ratio (MLR)
  • Neutrophil-to-Lymphocyte-Platelet Ratio (NLPR)
  • Neutrophil-to-Lymphocyte Ratio (NLR)
  • Platelet-to-Lymphocyte Ratio (PLR)
  • Systemic Immune-Inflammation Index
  • Systemic Inflammation Response Index (SIRI)
  • White Blood Cells
Get my health baseline

The full list of 100+ markers and 8 specialty add-ons available at superpower.com/what-we-test.